Cytokinetics Inc (CYTK)
56.18
+0.23
(+0.41%)
USD |
NASDAQ |
Nov 14, 11:28
Cytokinetics Total Return Level: 55.95 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 55.95 |
November 12, 2024 | 56.19 |
November 11, 2024 | 58.62 |
November 08, 2024 | 57.98 |
November 07, 2024 | 55.84 |
November 06, 2024 | 55.50 |
November 05, 2024 | 52.52 |
November 04, 2024 | 51.48 |
November 01, 2024 | 51.82 |
October 31, 2024 | 51.00 |
October 30, 2024 | 51.31 |
October 29, 2024 | 51.51 |
October 28, 2024 | 52.26 |
October 25, 2024 | 51.32 |
October 24, 2024 | 52.40 |
October 23, 2024 | 53.04 |
October 22, 2024 | 54.94 |
October 21, 2024 | 53.81 |
October 18, 2024 | 54.97 |
October 17, 2024 | 54.53 |
October 16, 2024 | 55.28 |
October 15, 2024 | 55.38 |
October 14, 2024 | 54.50 |
October 11, 2024 | 54.88 |
October 10, 2024 | 53.15 |
Date | Value |
---|---|
October 09, 2024 | 54.40 |
October 08, 2024 | 54.33 |
October 07, 2024 | 55.47 |
October 04, 2024 | 56.68 |
October 03, 2024 | 55.71 |
October 02, 2024 | 52.61 |
October 01, 2024 | 52.60 |
September 30, 2024 | 52.80 |
September 27, 2024 | 52.34 |
September 26, 2024 | 52.63 |
September 25, 2024 | 52.68 |
September 24, 2024 | 52.66 |
September 23, 2024 | 52.09 |
September 20, 2024 | 53.77 |
September 19, 2024 | 55.60 |
September 18, 2024 | 55.94 |
September 17, 2024 | 56.16 |
September 16, 2024 | 56.75 |
September 13, 2024 | 55.88 |
September 12, 2024 | 54.06 |
September 11, 2024 | 53.77 |
September 10, 2024 | 54.15 |
September 09, 2024 | 55.83 |
September 06, 2024 | 54.09 |
September 05, 2024 | 55.93 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
8.115
Minimum
Nov 14 2019
108.06
Maximum
Jan 08 2024
36.24
Average
35.27
Median
Total Return Level Benchmarks
Alnylam Pharmaceuticals Inc | 264.47 |
Biomarin Pharmaceutical Inc | 66.66 |
Catalyst Pharmaceuticals Inc | 22.80 |
Sarepta Therapeutics Inc | 112.48 |
Ocugen Inc | 0.9582 |